---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047385"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:37:12.165498+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix receives Nasdaq equity deficiency notice; equity of $1.872M below $2.5M minimum

## Summary
- On Nov 19, 2024, Nasdaq notified NanoVibronix it failed the $2.5M stockholders' equity rule based on $1.872M as of Sep 30, 2024.
- This adds to an existing bid price deficiency; both will be considered at the upcoming Nasdaq Hearings Panel hearing.
- The Company will present a compliance plan and request an extension, but continued listing is not assured.

## SEC filing metadata
- accession: 0001493152-24-047385
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315224047385/0001493152-24-047385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315224047385/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047385
- JSON: https://secwatch.observer/filing/0001493152-24-047385.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.